Again, thanks for sharing
Supplementary information Rights and permissions Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made
Neurodegenerative diseases including multiple sclerosis, Parkinson's disease, and Alzheimer's disease show preliminary preclinical evidence of BPC-157 benefits
Note the recommendations for pregnant and breast-feeding women are the same as everyone else over the age of 10
Conversely, patients with minimal adverse effects and inadequate therapeutic response may undergo more rapid titration under careful medical supervision
Roelofzen JH, Aben KK, Oldenhof UT, Coenraads PJ, Alkemade HA, van de Kerkhof PC,